-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 R+rYkjHKlvwSexvns4iXjHqOFLnphT+fXxcxUwmjz8Kzdj7b2iFXQwTV6iJCdLkZ
 jUllvbTzXT3Atxv3jA/VsQ==

<SEC-DOCUMENT>0000950123-10-039442.txt : 20100428
<SEC-HEADER>0000950123-10-039442.hdr.sgml : 20100428
<ACCEPTANCE-DATETIME>20100428134805
ACCESSION NUMBER:		0000950123-10-039442
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		5
CONFORMED PERIOD OF REPORT:	20100427
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20100428
DATE AS OF CHANGE:		20100428

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GeoVax Labs, Inc.
		CENTRAL INDEX KEY:			0000832489
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				870455038
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-52091
		FILM NUMBER:		10776261

	BUSINESS ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080
		BUSINESS PHONE:		678-384-7220

	MAIL ADDRESS:	
		STREET 1:		1900 LAKE PARK DRIVE
		STREET 2:		SUITE 380
		CITY:			SMYRNA
		STATE:			2Q
		ZIP:			30080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Geovax Labs, Inc.
		DATE OF NAME CHANGE:	20061002

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	DAUPHIN TECHNOLOGY INC
		DATE OF NAME CHANGE:	19940826

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	SUCCESSO INC
		DATE OF NAME CHANGE:	19910410
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>c99794e8vk.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<HTML>
<HEAD>
<TITLE>Form 8-K</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="margin-left: 0.25in; width: 7.2in;font-family: 'Times New Roman',Times,serif">
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 1pt solid black; font-size: 1pt">&nbsp;</DIV>

<DIV align="center" style="font-size: 14pt; margin-top: 12pt"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B>
</DIV>

<DIV align="center" style="font-size: 12pt"><B>Washington, D.C. 20549</B>
</DIV>

<DIV align="center" style="font-size: 18pt; margin-top: 12pt"><B>FORM 8-K</B>
</DIV>

<DIV align="center" style="font-size: 12pt; margin-top: 12pt"><B>CURRENT REPORT<BR>
Pursuant to Section&nbsp;13 OR 15(d) of The Securities Exchange Act of 1934</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B>Date of Report (Date of earliest event reported): April 27, 2010</B></DIV>

<DIV align="center" style="font-size: 24pt; margin-top: 12pt"><B>GEOVAX LABS, INC.</B>
</DIV>

<DIV align="center" style="font-size: 10pt">(Exact name of registrant as specified in its charter)</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
<TD width="32%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="32%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="32%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
<TD nowrap align="center" valign="top"><B>Delaware
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>000-52091
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>87-0455038</B></TD>
</TR>
<TR style="font-size: 1px">
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">(State or other jurisdiction<BR>
of incorporation)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(Commission File Number)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(IRS Employer Identification No.)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head -->
<TR valign="bottom">
<TD width="48%">&nbsp;</TD>
<TD width="2%">&nbsp;</TD>
<TD width="48%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
<TD align="center" valign="top"><B>1900 Lake Park Drive, Suite 380<BR>
Smyrna, Georgia
</B></TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top"><B>&nbsp;<BR>30080</B></TD>
</TR>
<TR style="font-size: 1px">
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
<TD valign="top" align="left">&nbsp;</TD>
<TD valign="top" align="left" style="border-top: 1px solid #000000">&nbsp;</TD>
</TR>
<TR valign="bottom">
<TD align="center" valign="top">(Address of principal executive offices)
</TD>
<TD>&nbsp;</TD>
<TD align="center" valign="top">(Zip Code)</TD>
</TR>
<!-- End Table Body -->
</TABLE>
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt">Registrant&#146;s telephone number, including area code: <B>(678) 384-7220</B></DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 12pt"><B></B></DIV>

<DIV align="center" style="font-size: 10pt"><FONT style="border-top: 1px solid #000000">(Former name or former address, if changed since last report.)</FONT></DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 6pt">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: </DIV>

<DIV style="margin-top: 6pt">
<TABLE width="100%" border="0" cellpadding="0" cellspacing="0" style="font-size: 10pt">

<TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Written communications pursuant to Rule&nbsp;425 under the Securities Act (17 CFR 230.425)</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Soliciting material pursuant to Rule&nbsp;14a-12 under the Exchange Act (17 CFR 240.14a-12)</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Pre-commencement communications pursuant to Rule&nbsp;14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</TD>
</TR>

<TR>
<TD style="font-size: 6pt">&nbsp;</TD>
</TR><TR valign="top" style="font-size: 10pt; color: #000000; background: transparent">
<TD width="3%" nowrap align="left"><FONT face="wingdings" size="2">&#111;</FONT></TD>
<TD width="1%">&nbsp;</TD>
<TD>Pre-commencement communications pursuant to Rule&nbsp;13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</TD>
</TR>

</TABLE>
</DIV>

<DIV style="width: 100%; border-bottom: 1pt solid black; margin-top: 10pt; font-size: 1pt">&nbsp;</DIV>
<DIV style="width: 100%; border-bottom: 2pt solid black; font-size: 1pt">&nbsp;</DIV>

<P align="center" style="font-size: 10pt"><!-- Folio --><!-- /Folio --> </DIV>
<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">This Form 8-K and other reports filed by GeoVax Labs, Inc. (the &#147;Registrant&#148;) from time to
time with the Securities and Exchange Commission (collectively the &#147;Filings&#148;) contain forward
looking statements and information that are based upon beliefs of, and information currently
available to, the Registrant&#146;s management as well as estimates and assumptions made by the
Registrant&#146;s management. When used in the Filings the words &#147;anticipate&#148;, &#147;believe&#148;, &#147;estimate&#148;,
&#147;expect&#148;, &#147;future&#148;, &#147;intend&#148;, &#147;plan&#148; or the negative of these terms and similar expressions as they
relate to the Registrant or the Registrant&#146;s management identify forward looking statements. Such
statements reflect the current view of the Registrant with respect to future events and are subject
to risks, uncertainties, assumptions and other factors relating to the Registrant&#146;s industry,
operations and results of operations and any businesses that may be acquired by the Registrant.
Should one or more of these risks or uncertainties materialize, or should the underlying
assumptions prove incorrect, actual results may differ significantly from those anticipated,
believed, estimated, expected, intended or planned.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;8.01 Other Events.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On April&nbsp;27, 2010, our Board of Directors filed a Certificate of Amendment (the &#147;Amendment&#148;)
to our Certificate of Incorporation to effect a 1-for-50 reverse split of our common stock. The
reverse stock split became effective upon the filing of the Amendment with the Secretary of State
of Delaware. This action followed stockholder approval, at a Special Meeting of Stockholders held
on April&nbsp;13, 2010, of the grant of discretionary authority to our Board of Directors to effect a
reverse stock split of our authorized, issued and outstanding common stock at any time within four
months after the date stockholder approval was obtained at any one of the following ratios, as
selected by our Board of Directors: 1-for-20, 1-for-30, 1-for-40, or 1-for-50. At its meeting on
April&nbsp;13, 2010, our Board of Directors determined to effect the reverse stock split at the 1-for-50
ratio.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Upon the filing of the Amendment, every 50 shares of our issued and outstanding common stock
were combined into one share of common stock. We did not issue any fractional shares in connection
with the reverse stock split. Stockholders of record who otherwise would have been entitled to
receive fractional shares will be entitled, upon surrender to our transfer agent of certificates
representing such shares, to a cash payment in lieu thereof equal to the fraction to which the
stockholder otherwise would have been entitled multiplied by $5.55, which was the closing price
(calculated on a post-split basis) of our common stock as on the Over the Counter Bulletin Board
(the &#147;OTCBB&#148;), on April&nbsp;26, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">On April&nbsp;28, 2010, to indicate the reverse stock split, the OTCBB will append a &#147;D&#148; to our
trading symbol and for a period of 20 trading days our common stock will be reported under the
symbol &#147;GOVXD.&#148; On May&nbsp;26, 2010, our trading symbol will revert to &#147;GOVX.&#148; The new CUSIP number
for our common stock is 373678200.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Additional information about the reverse stock split is available in our definitive proxy
statement filed with the Securities and Exchange Commission on March&nbsp;12, 2010.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">A copy of the Amendment effecting the reverse stock split is attached hereto as Exhibit&nbsp;3.1. A
copy of our form of common stock certificate following the reverse stock split is attached hereto
as Exhibit&nbsp;4.1. A copy of the press release issued on April&nbsp;16, 2010 announcing the reverse stock
split is attached hereto as Exhibit&nbsp;99.1.
</DIV>
<P align="center" style="font-size: 10pt; text-indent: 4%">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><B>Item&nbsp;9.01 Financial Statements and Exhibits.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">(d)&nbsp;Exhibits
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="11%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibit</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top">Exhibit&nbsp;3.1
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to the Certificate of Incorporation of GeoVax Labs,
Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top">Exhibit&nbsp;4.1
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of Common Stock Certificate</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top">Exhibit&nbsp;99.1
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Press Release</DIV></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->2<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>SIGNATURE</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly
caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Dated: April&nbsp;28, 2010
</DIV>


<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">GEOVAX LABS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD valign="top">By:&nbsp;&nbsp;</TD>
    <TD colspan="2" style="border-bottom: 1px solid #000000" align="left">/s/ Mark W. Reynolds
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Mark W. Reynolds&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="2" align="left">Chief Financial Officer&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>

</TABLE>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->3<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>

</TABLE>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>EXHIBIT INDEX</B>
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="11%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="77%">&nbsp;</TD>
</TR>
<TR style="font-size: 10pt" valign="bottom">
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Exhibit No.</B></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" style="border-bottom: 1px solid #000000"><B>Description of Exhibit</B></TD>
</TR>

<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top">Exhibit&nbsp;3.1
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Certificate of Amendment to the Certificate of Incorporation
of GeoVax Labs, Inc.</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top">Exhibit&nbsp;4.1
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Form of Common Stock Certificate</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top">Exhibit&nbsp;99.1
</TD>
    <TD>&nbsp;</TD>
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">Press Release</DIV></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->4<!-- /Folio -->
</DIV>




</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-3.1
<SEQUENCE>2
<FILENAME>c99794exv3w1.htm
<DESCRIPTION>EXHIBIT 3.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 3.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><U><B>Exhibit&nbsp;3.1</B></U>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>CERTIFICATE OF AMENDMENT<BR>
TO THE CERTIFICATE OF INCORPORATION<BR>
OF<BR>
GEOVAX LABS, INC.</B>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">GeoVax Labs, Inc. (the &#147;Corporation&#148;), does hereby certify that the Corporation&#146;s Certificate
of Incorporation originally filed with the Delaware Secretary of State on June&nbsp;17, 2008, as amended
by that certain Certificate of Merger filed June&nbsp;18, 2008, as further amended by that certain
Certificate of Amendment to the Certificate of Incorporation of the Corporation filed April&nbsp;13,
2010, is hereby further amended pursuant to Section&nbsp;242 of the General Corporation Law of the State
of Delaware.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The Corporation does also hereby certify that this Certificate of Amendment was duly adopted
by the Corporation&#146;s Board of Directors and by the stockholders of the Corporation in accordance
with the applicable provisions of Sections&nbsp;141, 222, and 242 of the General Corporation Law of the
State of Delaware.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%">The Certificate of Incorporation of the Corporation is amended as follows:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 4%; text-indent: 4%">The first paragraph of Article&nbsp;IV of the Certificate of Incorporation shall be deleted
in its entirety and replaced with the following:
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%; text-indent: 4%">&#147;The total number of shares of all classes of stock which the
Corporation shall have the authority to issue is 50,000,000 shares, which are
divided into two classes consisting of: (a)&nbsp;40,000,000 shares of Common
Stock, par value $0.001 per share, and (b)&nbsp;10,000,000 shares of Preferred
Stock, par value $0.01 per share.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%; text-indent: 4%">Upon the effectiveness of the Certificate of Amendment of the
Certificate of Incorporation (the &#147;Effective Time&#148;), each fifty (50)&nbsp;shares
of the Corporation&#146;s common stock, par value $0.001 per share (&#147;Old Common
Stock&#148;), issued and outstanding immediately prior to the Effective Time will
automatically and without any action on the part of the respective holders
thereof, be combined and reclassified into one (1)&nbsp;share of common stock, par
value $0.001 per share (the &#147;New Common Stock&#148;) (and such combination and
conversion, the &#147;Reverse Stock Split&#148;). Notwithstanding the immediately
preceding sentence, no fractional shares of New Common Stock shall be issued
to the holders of record of Old Common Stock in connection with the Reverse
Stock Split and the Corporation shall not recognize on its stock record books
any purported transfer of any fractional share of New Common Stock. In lieu
thereof, the Corporation shall make a cash payment equal to the Market Value
(as subsequently defined herein) of such fractional share of Common Stock to
holders thereof who would otherwise be entitled to receive fractional shares,
except for the provisions hereof, upon surrender of certificates representing
those shares to the Corporation&#146;s transfer agent. The ownership of such
fractional interests shall not entitle the holder thereof to any voting,
dividend or other right, except the right to receive payment therefor as
described above. For the purposes hereof, &#147;Market Value&#148; of shares of Common
Stock shall mean an amount per share equal to the closing price of the Common
Stock on the business day immediately preceding the Effective Time as
reported by the OTC Bulletin Board. Each stock certificate that, immediately
prior to the Effective Time, represented shares of Old Common Stock shall,
from and after the
</DIV>
<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 8%">Effective Time, automatically and without the necessity of presenting the same for exchange, represent
that number of whole shares of New Common Stock into which the shares of Old
Common Stock represented by such certificate shall have been reclassified (as
well as the right to receive cash in lieu of any fractional share interests
of New Common Stock as set forth above), provided, however, that each holder
of record of a certificate that represented shares of Old Common Stock shall
receive, upon surrender of such certificate, a new certificate representing
the number of whole shares of New Common Stock into which the shares of Old
Common Stock represented by such certificate shall have been reclassified, as
well as any cash in lieu of fractional share interests of New Common Stock to
which such holder may be entitled as set forth above.&#148;
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">The remainder of the Certificate of Incorporation shall remain unchanged and in full force and
effect.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">IN WITNESS WHEREOF, the Corporation has caused this Certificate of Amendment to be signed on
April&nbsp;27, 2010.
</DIV>

<TABLE width="100%" border="0" cellspacing="0" cellpadding="0" style="font-size: 10pt">
<TR>
    <TD width="48%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<TR>
    <TD valign="top" align="left">&nbsp;</TD>
    <TD colspan="3" align="left">GEOVAX LABS, INC.<BR>
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" style="border-bottom: 1px solid #000000" align="left">/s/ Robert T. McNally
&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left">ROBERT T. MCNALLY&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR><TR>
    <TD align="left">&nbsp;</TD>
    <TD colspan="3" align="left" nowrap>Chief Executive Officer/President&nbsp;</TD>
    <TD>&nbsp;</TD>
</TR>
</TABLE>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">ATTEST:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="30%">&nbsp;</TD>
    <TD width="5%">&nbsp;</TD>
    <TD width="65%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mark W. Reynolds
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">MARK W. REYNOLDS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top" nowrap><DIV style="margin-left:0px; text-indent:-0px">Chief Financial Officer/Corporate Secretary</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->1<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.1
<SEQUENCE>3
<FILENAME>c99794exv4w1.htm
<DESCRIPTION>EXHIBIT 4.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 4.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;4.1</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">Text of GeoVax Labs, Inc. Common Stock Certificate:
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="30%"></TD>
    <TD width="5%"></TD>
    <TD width="30%"></TD>
    <TD width="20%"></TD>
    <TD width="15%"></TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">NUMBER
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">SHARES</TD>
</TR>
<TR valign="bottom"><!-- Blank Space -->
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="right" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom">
    <TD align="left" valign="top">GV <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">GEOVAX LABS, INC.
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">INCORPORATED UNDER THE LAWS OF THE STATE OF DELAWARE
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="25%">&nbsp;</TD>
    <TD width="60%">&nbsp;</TD>
    <TD width="15%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap align="left" valign="top"><DIV style="margin-left:0px; text-indent:-0px">COMMON STOCK
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD nowrap align="left" valign="top">COMMON STOCK</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">SEE REVERSE FOR</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">CERTAIN DEFINITIONS</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD align="center" valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD align="left" valign="top"><DIV style="margin-left:0px; text-indent:-0px">THIS CERTIFIES THAT
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">CUSIP 373678 20 0</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">is the owner of
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">FULLY PAID AND NON-ASSESSABLE SHARES OF THE PAR VALUE OF $.001 EACH OF THE COMMON STOCK OF
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
<B>GEOVAX LABS, INC.</B> <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
Transferable on the books of the Corporation by the holder hereof in person or by duly authorized
attorney upon surrender of this Certificate properly endorsed. This Certificate is not valid until
countersigned by the Transfer Agent and registered by the Registrar.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; text-indent: 4%">IN WITNESS WHEREOF, the Corporation has caused the facsimile signatures of its duly authorized
officers and its facsimile seal to be hereunto affixed.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Dated:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="35%">&nbsp;</TD>
    <TD width="19%">&nbsp;</TD>
    <TD width="35%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">/s/ Mark W. Reynolds
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
CFO and Secretary
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">/s/ Robert T. McNally
<DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
President and CEO
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">GEOVAX LABS, INC.<BR>
INCORPORATED<BR>
SEAL<BR>
DELAWARE
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="40%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="30%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left">Countersigned and Registered:</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="3" valign="top" align="left"><B>AMERICAN STOCK TRANSFER &#038; TRUST COMPANY, LLC</B></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px"><!-- Blank Space -->
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(New York, NY)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>Transfer Agent and Registrar</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">The following abbreviations, when used in the inscription on the face of this certificate, shall be
constructed as though they were written out in full according to applicable laws or regulations:
</DIV>
<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="10%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="22%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="17%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="3%">&nbsp;</TD>
    <TD width="8%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="7%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="10%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD nowrap valign="top"><DIV style="margin-left:0px; text-indent:-0px">TEN COMM
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">-
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">as tenants in common
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top" nowrap>UNIF GIFT MIN ACT
</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">-
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">Custodian
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">TEN ENT
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">-
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">as tenants by the entireties
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Cust)
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">(Minor)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">JT TEN</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">-</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">as joint tenants with right</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"> under Uniform Gifts to Minors</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">of survivorship and not</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">Act <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">as tenants in common</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">UNIF TRF MIN ACT</TD>
    <TD>&nbsp;</TD>
    <TD align="center" valign="top">-</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> Custodian (until age __)</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> under Uniform Transfers</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(Minor)</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD colspan="5" valign="top" align="left">To Minors Act <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">(State)</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt">Additional abbreviations may also be used though not in the above list.
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">For Value received, <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U> do hereby sell, assign and transfer unto
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt">PLEASE INSERT SOCIAL SECURITY OR OTHER<br>
IDENTIFYING NUMBER OF ASSIGNEE
</DIV>

<P>
<DIV style="width: 30%; border: 1px solid black; padding: 8px;">



<DIV align="left" style="font-size: 10pt; margin-top: 10pt">&nbsp;
</DIV>
</DIV>



<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV> PLEASE PRINT OR TYPEWRITE NAME AND ADDRESS INCLUDING ZIP CODE OF ASSIGNEE
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>


<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV> Shares
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">of the Capital Stock represented by the within Certificate, and do hereby irrevocably constitute
and appoint <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt"><DIV style="border-bottom: 1px solid #000000; font-size: 1px">&nbsp;</DIV>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Attorney to transfer the said stock on the books of the within-named Corporation with full power of
substitution in the premises.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Dated: <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 50%"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">NOTICE: The signature to this assignment must correspond with the name as written upon the face of
the Certificate, in every particular, without alteration or enlargement, or any change whatever.
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt">Signature(s) Guaranteed
</DIV>

<DIV align="center">
<TABLE style="font-size: 10pt" cellspacing="0" border="0" cellpadding="0" width="100%">
<!-- Begin Table Head --><TR valign="bottom">
    <TD width="2%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="50%">&nbsp;</TD>
    <TD width="1%">&nbsp;</TD>
    <TD width="45%">&nbsp;</TD>
</TR>
<!-- End Table Head -->
<!-- Begin Table Body -->
<TR valign="bottom">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">By:</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="font-size: 1px">
    <TD valign="top"><DIV style="margin-left:0px; text-indent:-0px">&nbsp;
</DIV></TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top"><DIV style="font-size: 1pt; border-top: 1px solid #000000">&nbsp;</DIV>
</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<TR valign="bottom" style="padding-top: 1px">
    <TD colspan="3" valign="top" align="left">THE SIGNATURE(S) SHOULD BE GUARANTEED BY AN ELIGIBLE GUARANTOR
INSTITUTION (BANKS, STOCKBROKERS, SAVINGS AND LOAN ASSOCIATIONS
AND CREDIT UNIONS WITH MEMBERSHIP IN AN APPROVED SIGNATURE
GUARANTEE MEDALLION PROGRAM), PURSUANT TO S.E.C. RULE 17Ad-15.</TD>
    <TD>&nbsp;</TD>
    <TD align="left" valign="top">&nbsp;</TD>
</TR>
<!-- End Table Body --></TABLE>
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>c99794exv99w1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<HTML>
<HEAD>
<TITLE>Exhibit 99.1</TITLE>
</HEAD>
<BODY bgcolor="#FFFFFF">
<!-- PAGEBREAK -->
<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="right" style="font-size: 10pt; margin-top: 10pt"><B>Exhibit&nbsp;99.1</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><IMG src="c99794c9979401.gif" alt="(GEOVAX LOGO)">
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><B>GEOVAX LABS ANNOUNCES REVERSE STOCK SPLIT;<BR>
APPLIES FOR LISTING ON NASDAQ</B>
</DIV>


<DIV align="center" style="font-size: 10pt; margin-top: 10pt"><I>1:50 Reverse Split to be Effective After Market Close on April&nbsp;27, 2010<BR>
Ticker Symbol to Change from GOVX to GOVXD for 20 Days</I>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>ATLANTA, Ga., April&nbsp;16, 2010 &#151; GeoVax Labs, Inc. (OTC Bulletin Board: GOVX)</B>, a biotechnology
company that creates, develops, and tests innovative HIV/AIDS vaccines, today announced it will
implement a 1-for-50 reverse stock split effective following the close of business on April&nbsp;27,
2010. After the reverse stock split, the Company will be authorized to issue up to 40&nbsp;million
shares of stock, of which approximately 15.7&nbsp;million shares will be outstanding. For the 20-day
period beginning April&nbsp;28, 2010, GeoVax&#146;s ticker symbol will be &#147;GOVXD&#148; to reflect the post-split
price. Following that period, the ticker symbol will revert to &#147;GOVX.&#148;
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">The Company also announced that it has applied for listing its common stock on NASDQ Capital
Market. The reverse split is intended, among other things, to allow the Company to meet NASDAQ&#146;s
minimum stock price requirements. The Company&#146;s listing on NASDAQ is subject to review by NASDAQ
and is dependent upon the Company meeting all relevant quantitative and qualitative listing
criteria.
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">Robert T. McNally, PhD, President and CEO of GeoVax, commented, &#147;I am grateful for the support of
the shareholders in approving our reverse split; 78% of all outstanding shares voted in favor of
the proposal, with 91% of the shares represented at the special shareholder meeting voting in
favor. In addition to helping us meet the requirements for listing on NASDAQ, we believe the
reverse stock split will help us attract new institutional and retail support in the market.&#148;
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>About GeoVax Labs, Inc.</B>
</DIV>


<DIV align="justify" style="font-size: 10pt; margin-top: 10pt">GeoVax is a biotechnology company developing human vaccines for diseases caused by HIV-1 (Human
Immunodeficiency Virus &#151; AIDS) and other infectious agents. Our goals include developing AIDS
vaccines for global markets, manufacturing and testing these vaccines under GMP/GLP conditions (FDA
guidelines), conducting phase human trials for vaccine safety and effectiveness, and obtaining
regulatory approval to move the product forward. Preventative phase 1 human clinical trials
tested GeoVax&#146;s DNA/MVA vaccine. All tested combinations and doses of our DNA and MVA AIDS vaccines
in human volunteers demonstrated ability to raise Anti-AIDS immune responses as well as for their
safety. Successful results from all phase 1 testing of GeoVax&#146;s vaccines supported the initiation
of the first phase 2 testing of our product. GeoVax&#146;s phase 2 human trial began in January&nbsp;2009 and
involves 225 participants at sites in the United States and South America. Long term, we expect
that GeoVax will enter into agreements to out-license manufacturing technology to major vaccine
production companies and distribution rights to key companies in several global markets in return
for upfront fees, collaborative development agreements, and royalties on sales and distribution
revenues. Internal vaccine manufacture and sale will be considered by GeoVax. For more
information, please visit <U>www.geovax.com</U>.
</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">MORE
</DIV>

<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>

<!-- PAGEBREAK -->
<P><HR noshade><P>
<H5 align="left" style="page-break-before:always">&nbsp;</H5><P>

<DIV style="font-family: 'Times New Roman',Times,serif; margin-left: .25in; width: 7.20in">

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><B>Forward-Looking Statements</B>
</DIV>

<DIV align="justify" style="font-size: 10pt; margin-top: 10pt"><I>Certain statements in this document are &#147;forward-looking statements&#148; within the meaning of the
Private Securities Litigation Reform Act. These statements are based on management&#146;s current
expectations and are subject to uncertainty and changes in circumstances. Actual results may
differ materially from those included in these statements due to a variety of factors, including
whether: GeoVax can develop and manufacture these vaccines with the desired characteristics in a
timely manner, GeoVax&#146;s vaccines will be safe for human use, GeoVax&#146;s vaccines will effectively
prevent AIDS in humans, vaccines will receive regulatory approvals necessary to be licensed and
marketed, GeoVax raises required capital to complete vaccine development, there is development of
competitive products that may be more effective or easier to use than GeoVax&#146;s products, GeoVax
will be able to enter into favorable manufacturing and distribution agreements, and other factors,
over which GeoVax has no control. GeoVax assumes no obligation to update these forward-looking
statements, and does not intend to do so. More information about these factors is contained in
GeoVax&#146;s filings with the Securities and Exchange Commission including those set forth at &#147;Risk
Factors&#148; in GeoVax&#146;s </I><I>Form 10-K</I><I>.</I>
</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 50%"><B>Contact</B>

</DIV>

<DIV align="left" style="font-size: 10pt; margin-top: 10pt; margin-left: 50%">At The Investor Relations Group:<BR>
Investor Relations<BR>
James Carbonara / Jason Strominger<BR>
or<BR>
Public Relations<BR>
Janet Vasquez / Robin O&#146;Malley<BR>
(212)&nbsp;825-3210

</DIV>

<DIV align="center" style="font-size: 10pt; margin-top: 10pt">###
</DIV>



<P align="center" style="font-size: 10pt">&nbsp;

<P align="center" style="font-size: 10pt"><!-- Folio -->&nbsp;<!-- /Folio -->
</DIV>



</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>c99794c9979401.gif
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 c99794c9979401.gif
M1TE&.#EAV@!-`.8``$MAG,3*W:2MR_'R]O3U^,O2XMSAZVM\K*BRSH^<P+S$
MV7N*M3)*C2Q#BEMSIB(\A='5Y#Q2DA(M?=K=Z822NJRWT!0P?AHU@1TY@YFD
MQ72#L>'D[5%DG96APUIMHXB5O=38YHR9OU5KH&V`KNWP]$%;EOCY^^WN].;I
M\&)UJ"U)C+"YTNGL\K6^UGB4M<?.X,''V^CJ\4I>F=7;Z-_B[!`K>S=.D$%6
ME61ZJA8S@+/#U21`AV!RIG6(LR5"B/KZ_+G!UX&-MT5<F/S\_9VIR'*!KSY8
ME313D7B%LN/F[K>]U<G,WY":OK.^U!`K?).HP]C:YXBAOH67M["\TRI!AYJG
MQVZ'KVAWJ1$K>[2YTX>:O=_@ZR4[>KW+VN+H[V]^KN;G\%V"J>SM\PXI=B='
MBE)FGYNQQY"?POO\_;2[U+*[TQ,O?1\_ABU/CO?W^DE8EK_"V*"GQS5:E'^.
MN)>JR$]LGE!VH:^WS^_P]3E0D>KN\Q`K=_O[_"U$?A$L?/___R'Y!```````
M+`````#:`$T```?_@'^"@X2%AH>(B8J+C(V.CY"1DI.4E9:7F)F:D1L>5`V@
M#49@FZ6FIZBIJ`,>:WZO%CPO;JJUMK>XJ@(86*]K.TFYPL/$Q8H?K[`IQLS-
MF20*.D]:2-5((B79VMD:UDA:3U,%FZ[)&@/.Z<8$&U`O,!4"&2$?/0=7''D-
M5!@Y$LD``PH<"+"&A0N?&`A)<:4(A0]G!"!0$`#"EAB&A"23H$"=1U0$:!2`
M@2#!%QX`;C1X8*$7P9<P8\I\*0%#`QL`/%Q9(`;&!9=4('P<2HG`A!<9D,C`
M,+.ITZ=0`QITDV)C&A`A!(!@0;2KH0TKD'!0\3.JV8(U?:@`P+:MV[<W_U3L
MP"#!)=0:-_Z4K9'#C8@:`#'8$/%!`5>OPV(TB4.AP87'%LY*E?```X,U*GQ8
M*6''Q14M<PX\J0!E2Q(\FWZ02+)E`H07`=0@B'/F0Y$R-S#4P+(F"Y-D-62P
M*/MR!X`4"X"80&QJ1H`$'`!$T'V6-QL+;!X(.<(61P\'(W`\"7#4`(097HCR
M03&A0(`!#7IAL0#BPP6G:ZC(./`!`00"S$%B`AXGS%$-`X"9)<$:%I!1@@\,
M&!&&"F$@H$,%.I`08",0_.,'%C;\`48+57QP@`@W[.!A3#5@4`8%_BVWX2%J
M"'``&PE&5<,%.>2`01N=/6&&`3-6P@%@-4@0@O\B`2R`(E,SU0!`&A-LZ,8,
M$(Q`16112?`8&7(X4`</&R211`RT%%E)%BM2`<D`$&C!``87Y#@07T($\$(P
M0P$!0`YF[4B&"AC@T(4"+ZA9"BL`-3`)"G74L=T1%EBPHE0YJ,"!`UND60P>
M'_#`I5,[LN%#"5K008>&BJ*2P:@2"'')!A4@4,<1;:@@P:X$K<%#"R>@(\P&
M'5PZ$Q82,)#"&3-,X&FKJ.2Q(@-*:$+###JX,,(1;/!H9S([1"`#$,+64@`%
M#T"U!@-7J"$CM(?@`<&\$(#`YR09$.='$:DH4$$/1Y"!@:4#Y5!&#W@,@0H,
M#-@5)15%H,`)$*$:883_#")DK+$(!U`0`(#$K,#&*UA<H,(5($>R0$`=V3)%
M#R.04:G#R;#Q`1`I7^(&$0]\&],#'Q`)R0P'0.F4K,3\@$`;+7THP0J2X`&H
M'SOR@!HN5ZX@0AO]K$'S!4;$L8$E;B2@PE,7?`%'SHVTP,'43]7PP-C$F)``
ME,B*<$(D(_R#+`9W&#/%&48`P,:N--]01;F0`,$!J3LLL(0D/RQ`750E`\&,
M!ES.EP8D/Y0`&&\-W%OW!@6,P`8&7@>$@0:3/[)!$4\U$,+5D8!Q@\^4,1#!
M[\#GP<#PP_<8`#,"P+U&`C\\`@2.5.<08CIN!-"!$=<9N\,2;".RQ`XTOX3!
M_QS/0@*!#7:V>``,W1\"@1`P,,/*U#4(03<C>*3KM`H.#.7&&4>X@+$DP(/R
M&2($3T&"Q"B!!QL$Q`9$D$0!Q-`,!.AO/G-P!!XL@*0<?,$K*#C##F9&,C\<
MH0/O(@0*D&"LEUP@=I28@0@<9C]X_0$$;?#0&E+0/D-0(`<)>@`"$$,`!7B`
M#'#S0TT^D,(_G.`+4<H!&_)2"3=\H4X?\D,.>&C#`<R!.FM@0_P640`&O((O
M(M@0"J)`AOL`Y`(=(`0!/-#"@=2D"I>`@AL_M`895,F&?X"`S,Y(146TH!PM
M&N*,X&"$/?+%""E;0CEB(H$RF(X2`!B5'P#00T6EH/]I+4J4(@"0(">PH0)J
M(@`2!+(,07`@?%+AD0`PD05>[*]E@!3$#/:2@SPH@@EPR\$5<">(`@@A#R*(
M@B`F()T(Y*$'S#!!$/:HQ>,5((D$P4(.TM!$29@@!'7QPQI\H(94X$$!//"`
M.M?I`1Z`H).%@((`YG"%>GXA!`HHUPFJD@P`*$(`'L("`\IE@N>4@8,7L,$"
M$%"`*MR`:@V(H`E>4`2W>*"<B9C``2PJ`#T\@@`+8(#?))"`/P2@C@7!P!DR
M00,S)D,(Q-P$$%)`S8#X8`'C2`0-$+``_07D`CP0P/'^,(.`VF"!AB`!/S_D
M@6(*@`=8E(H-$D`!O\%1$%O_D(%==B"`]@%!!@F2@`60,(D.1`991PW`3"0P
MU%DAZ$,66``J2@#$F&`A!7M#Q`TT21`,4.`/&]R((@U!!`_M2`0_X-E:-V*$
M06RA`2N2``?R.H@8/#09%LC#%O#%)0GD`#8LND!3,S$!*IRQ`4(QA1N,QJ(#
M\.$0#H#E0%20,("2;+2&J$`RL"`#-YB`!V8IY!]:<('6O6*P@H@`0')P@S]*
M(@`^..,%`J#6F*SA`)H(`"(YD`BBO>6[;"D#*@?AA08`1)L'B,@9Z&@7"5S!
M$!J0B@Q"$(<,7*&NR<@#!6T@GQPXEQ`1"&N5-+"B'7$@`[*A`/@&(MP?!.%P
MR<!`_Q8&`0?@Y(`,.9T$'VCZ"AD8X*0P\=(FJDNU-")"N<>Z@"+=,`*`2.`+
M$'CM(`)0!`Y2S0*?&X0"UI"@&C`@"XPKP!P"@MT.[/:OA>@0R2)`@`HT38E7
MT!PADB!"FCF*$#]``C4;T((_T&`'P"'#!Q@GB:+-9PI_F,!;"2+B[`+'Q(:`
M`E3*(`@%V-(/&`B!`?]@-R[Y6,8L*(%=/(R(!#SY`>0Q[ROR@!%"?,`E2G+#
M#5R"!0#L^0]I4'0R&&`(-Y3@R6O@[BIW2X5N1N(`%E@#&2CXAQY,4B">U4!V
M#>O/0U2X=H*8(2R0>XCX)@,$@M!M,EJ9"`H`)P)_"`)F9_\YB`%@L08[&&Y`
M;W#)0BCAU=,KQ`N.P.-7\`H@#_CO)`)`%PR4`&1;P,#EI+(&.%]B`F#^$`-(
M88@*YR`";\BWOO7MTD4+PL:5EG$B^(`^I@KB"BZY`-06`5:XOH`&`>7T((SL
M;;D*(:RI582O7U%K0RP!OP)9PPPP`8==,:#1?^"#`$S[$@8@U1($N"P6,)!Q
M0L!!`_1&A!M6E(,_5,"P8US$QB_P!P.<[14E9405/"2!(7K`)6N0LAN.](KI
M_H$Z$AB!J0LQ@6DA`@\T-6XR1'N)(<```SYH`Q,*88(,L(3->LO$%1)D@<`9
M8@*'441`_D`!)`F7$!.8@N`%CX/_%6&ZL\!F!!3TMP:H@?@5[_6Y&VMP`#=,
MP,]27@0?+D?TK],T1R4#`,HID073<@`!IJ[`=<+'%SQB0@``D34E]NX`)"6]
M$+1[20T&8-L6W4\1+`CP*URO`DC3X`_`A44YJ[NC1V@Z\H@8P&7/R(8X5L+L
M5-A#'GYO"`'0E2`7P`$FQ'#HO$>"]K;O/DJ3\0?84PT#W$<$&/*0H#@(X@PK
M"L)J1W<!6C"_YX[P?(J0`=A4`W16"4K`!1<P`N;G>6R`3:_P`/US"4A@%QQP
M:8NP=W/@=X:`#+I'=(?D"S6742RW!G;W!SLP.D)P!0!A?9>7#)FW"%'E!XDP
M`"SW4VLG_PD#D`)]P`7,U@A-E@>L(Q`YL``K50DT<#D20`'PA`A[AP"M4P,Q
M^`<>.!!8T`")8G2]4`/DPPB%Y6WC]0=0Y&WAI$VL1@"7PP--R`?:Y1)_-P@L
MH!$;T3J>=82.H`=$X`$E(`5DU@@3$`(\$&\NQ@`8V`@K<T8YD`$"YPA[)S7R
M86F.A@$)T`246(E-``3W\Q?R)@6+$`!O-1](]@>H]BU84$@)`#W0EF&(<`?]
MY@=R=0A*$!`^DB!8D`>4M0A>X`(`0`0;T(2+,`!G<&=G%`$C*""B@UD+\'*,
ML'=_0$JOD(B.EH.+\#C]5(R#8`(>L!%L<#\?`(%^`&=;`#<OMO]U?X``/F`G
MG5<(I;=<!X!BL(`#?4@(;J`'/Z`',Y!XF<`'%7!TF&4UE!`#/;-;0B`TC<",
M:N!G%X!17N8(%9""9_0`"5,(0]`%.)`C$D`&C!-=`2$!(R<(`W`$2G@``Z`P
MA,`'>.".`&$(,*`"M!A7@=0/HP.-B-`$5F`'XK8)!;4`DS1S!Q!3CA``\;%;
M%E`&1%!MAL",5)$C%U`$#;@(,9"-["A*?[`%/:"19^0#.38(!Y!$$N!N?P`%
MNF(7&&!_@U``/(!2;%<&*V(!#"`40U`%=)$,0E0(1M2#*$.2JH"''G!!&+``
M*^"3BP`!TP<<.\`!*7``(Y"8BJF8*_+_`(.P`9KV"C9P!0_Q`99YF9<9`D%G
M9^<E`0U`&`=`!<9B`4_`-@&@*V>D`K@T"%5U*1?0`#CP`67P`++EF,W6`W6%
M+'D0=']@.<FP!@T@&E:@3C8@!`O`F[@`!2$``#]A$#>``/&8""P@`A+@,TZ!
M;&5Y@TTQ'T'7`E`Y$PQ`!,UC"`JP1Z]8"`20!46P?B^!G76&-S4A`'CY!VX`
M`*_F63EP`3:#!X5H"V5S`U@D`1]P?(]`!)'Y%`)5"!LPF$V1!\^"!-X8$#(0
M?X2P`+LA!+=H"`0H6YM&'5A0!FEBH``1"]T3`#;0;2UB`W.P!5N`!A_!!R`0
M!/K3EP3*"";`_S`<^A(YL%GR>`>TZ118D)6"D`1E0!#0!@/S>0@;8"DAL(B'
M(`;4&3Y80`508VRO@`'Q(P9J*1\6$`"79@`8X`1+B8D;0@-`D`"`P@`'D!Z-
MD`0MT`$X,(,PP1=2>8U(X0#KEDT/$`2&0`-WT`-D8!`ID`%UN@B[@YR)D`0K
M0`%DH$5U4`4%('`"<([(`@!&4XIM%7T%`)B-,`"T$0>3`P-QH(RGX`9TT`,1
MX`-DX`$:H)"Y]*J90`$^X`,8D`<%8`1]8(VHX!I3(`4B8`0.(`55T`(TP"JP
M>JR0(`-D```^P`:J<WM),P4Z(`!64`=["`$&T)3(NJV$P`&JVJSJ!O^MS4``
M2=`%0M(%W)JNAC`"$2`$5N`"\(JNZCJO]%JO]GJO^)JO^KJO_-JO_OJO`!NP
MR#H$),`"QFH)`\`"VGH*>,"BT2FPE3`[5Y!T2U!/"@`!]60/7X!F@B``EAD#
M,5"M.8@5'Q`"B9<%EJD`]("9&08"9W``D1("-VD*'0`*O`:QEQ`"/?**`+4&
M&2`%.V(#EB)[!@!9'@`&<&D#=H<`D6$!BG0&:R`!1'`%*\(;2,`52``8_N`'
M#Y!SJ'``-0"=.+L)J_19@O!T$B``")<#"%`GOO0'1F`I,O`'*@"<`*(',K`&
M;5`#*K"I3(%HDW8!;,$Z$I`'""`!8Z`%?U#_!1?@!+?G!080#`-@``80`T,`
M`O-R+R8`!>>!<DDP+_A(`"2`ET,0`P?K!BR0,T/``AXUMH9@5O0A"`>@11"`
M`TY@`2S@`,D"6'%9+3ZP!K+7C5[B!U=``GC`"P_`!&'*`<$`>\D">S401P(@
M,XHK"".``2H``0K`-0=``U-#!2F`&@B@&](S2VZ0![`@5Q-0`FD44CS``#G@
M`ZCD!@>P`SFP`[)'`?![`660J:X[9!+P"2M1`Q[@!AK@!"K0?I)E`BO32@+@
MDO1Y&450D6<`(&"F`03@"M;W!P[@!/Z$M@R`!"VPB)>7`W#P`CZB``VC`14@
M!&NP!"_0#_7@)2;J_P<>D`""M@(5L`9-A;X,L``.U),B8,-GH%44<&T,(`"X
MR0,/"["O9!.@\"%-^DI-U0(6T`!;H`)4D%.B8G<K$P$L@`P,T(MKX`15``(+
MHI`EX`0\`%ASD`<M(0%D.0@Y8`%G4`980`$#\`X%``%J"04RX`<'.`<+4"P<
M<'P!T`,!$%\\D6IXI`$U$`$KL`870`1")@$RD`%K\``4\`)[XKJ$8%Y+XF6`
M(@`38%YKA\(WH&SG^0`1@!KDYP>#40)^<`,QH`">!0$K($Y_M`$+(@`.^P=$
MRK7_M0\%L`8W(`8DT`J\X5D%0!>A^`<=@`72F&M8D`4%L"`=(01.X`%5D/\^
M.3`_2C0'XPG*?^`/5V8YJH:F7?D'(>`*GK5P`&5]SCBB2I``3I`#?)``._):
M&W`V90`"D<%L+^!9=>K"`;8D*5`#1=!DE!$#@/(!?P`#04`!5A`<?S``3!`$
M$*`K?_`;#+!9#S`&!G`&?C!4)+`!,&H`;F!G-;!PYKPKMOD%@!("$;`K_=,!
M0*1-BB0M1`(#2C142[H&`L`!3C"W7S!S*5$G#`!L#_7#/0!915#.?^`!-<"W
M?Q`#RO4%`:`1>>%`0E`%#+`#*]`"A1L'A8<!6V`!R#9#:E"Z:^!+AP0TEO,`
M27`0,KL#>X"/KLL#E3'*&O`82D`H&"`(>,"<#S##6G>=%WA0!K8SGGS```V0
M`39`!1VP`3(`"E2@`B50!*D%`A[`%)YY`)<T!PW``(I$!%302RJ!70H@!`-S
M`T3`!P1P!2PA6C,`!`U``6@@`U0`!1/=`,E,`*:]!A@0`9\CUACP`/C+:J#L
M&A"0)ALP+W`R+X(P!-!-H#&@%?3)HL^R`5L@!C2P!0/@!N/-HDE0H@(@`-;8
ML+\'`A4P`2>P!70S`/X29!4@90U+`F@`WN@P`/0M8P:``##@N2U0`;HJ"8$`
"`#L_
`
end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
